![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SERINC1 |
Gene summary for SERINC1 |
![]() |
Gene information | Species | Human | Gene symbol | SERINC1 | Gene ID | 57515 |
Gene name | serine incorporator 1 | |
Gene Alias | TDE1L | |
Cytomap | 6q22.31 | |
Gene Type | protein-coding | GO ID | GO:0006575 | UniProtAcc | Q9NRX5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57515 | SERINC1 | LZE4T | Human | Esophagus | ESCC | 1.32e-15 | 5.72e-01 | 0.0811 |
57515 | SERINC1 | LZE7T | Human | Esophagus | ESCC | 6.03e-04 | 2.15e-01 | 0.0667 |
57515 | SERINC1 | LZE8T | Human | Esophagus | ESCC | 7.00e-12 | 2.61e-02 | 0.067 |
57515 | SERINC1 | LZE20T | Human | Esophagus | ESCC | 4.79e-12 | 7.22e-02 | 0.0662 |
57515 | SERINC1 | LZE22T | Human | Esophagus | ESCC | 5.02e-04 | 2.29e-01 | 0.068 |
57515 | SERINC1 | LZE24T | Human | Esophagus | ESCC | 6.14e-13 | 6.09e-01 | 0.0596 |
57515 | SERINC1 | LZE6T | Human | Esophagus | ESCC | 1.02e-02 | -4.82e-02 | 0.0845 |
57515 | SERINC1 | P2T-E | Human | Esophagus | ESCC | 2.22e-26 | 4.56e-01 | 0.1177 |
57515 | SERINC1 | P4T-E | Human | Esophagus | ESCC | 5.86e-15 | 3.54e-01 | 0.1323 |
57515 | SERINC1 | P5T-E | Human | Esophagus | ESCC | 2.29e-10 | 3.50e-01 | 0.1327 |
57515 | SERINC1 | P8T-E | Human | Esophagus | ESCC | 7.03e-30 | 6.42e-01 | 0.0889 |
57515 | SERINC1 | P9T-E | Human | Esophagus | ESCC | 6.05e-09 | 1.67e-01 | 0.1131 |
57515 | SERINC1 | P10T-E | Human | Esophagus | ESCC | 1.18e-22 | 5.70e-01 | 0.116 |
57515 | SERINC1 | P11T-E | Human | Esophagus | ESCC | 2.33e-13 | 6.22e-01 | 0.1426 |
57515 | SERINC1 | P12T-E | Human | Esophagus | ESCC | 3.90e-45 | 9.16e-01 | 0.1122 |
57515 | SERINC1 | P15T-E | Human | Esophagus | ESCC | 1.79e-26 | 7.27e-01 | 0.1149 |
57515 | SERINC1 | P16T-E | Human | Esophagus | ESCC | 4.80e-35 | 9.42e-01 | 0.1153 |
57515 | SERINC1 | P17T-E | Human | Esophagus | ESCC | 2.28e-04 | 4.60e-01 | 0.1278 |
57515 | SERINC1 | P19T-E | Human | Esophagus | ESCC | 3.67e-06 | 9.90e-01 | 0.1662 |
57515 | SERINC1 | P20T-E | Human | Esophagus | ESCC | 7.16e-14 | 2.61e-01 | 0.1124 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00086544 | Esophagus | ESCC | phospholipid biosynthetic process | 162/8552 | 253/18723 | 2.59e-09 | 5.73e-08 | 162 |
GO:00066433 | Esophagus | ESCC | membrane lipid metabolic process | 130/8552 | 203/18723 | 9.29e-08 | 1.54e-06 | 130 |
GO:00066446 | Esophagus | ESCC | phospholipid metabolic process | 218/8552 | 383/18723 | 5.37e-06 | 5.59e-05 | 218 |
GO:00066652 | Esophagus | ESCC | sphingolipid metabolic process | 96/8552 | 155/18723 | 3.21e-05 | 2.66e-04 | 96 |
GO:00066505 | Esophagus | ESCC | glycerophospholipid metabolic process | 174/8552 | 306/18723 | 4.92e-05 | 3.85e-04 | 174 |
GO:00065757 | Esophagus | ESCC | cellular modified amino acid metabolic process | 112/8552 | 188/18723 | 8.31e-05 | 6.06e-04 | 112 |
GO:00440918 | Esophagus | ESCC | membrane biogenesis | 38/8552 | 55/18723 | 3.78e-04 | 2.19e-03 | 38 |
GO:00464864 | Esophagus | ESCC | glycerolipid metabolic process | 211/8552 | 392/18723 | 6.51e-04 | 3.46e-03 | 211 |
GO:000657511 | Liver | Cirrhotic | cellular modified amino acid metabolic process | 70/4634 | 188/18723 | 9.04e-05 | 9.69e-04 | 70 |
GO:00440914 | Liver | Cirrhotic | membrane biogenesis | 25/4634 | 55/18723 | 6.51e-04 | 4.96e-03 | 25 |
GO:0006643 | Liver | Cirrhotic | membrane lipid metabolic process | 69/4634 | 203/18723 | 1.89e-03 | 1.19e-02 | 69 |
GO:000657521 | Liver | HCC | cellular modified amino acid metabolic process | 119/7958 | 188/18723 | 6.47e-09 | 1.67e-07 | 119 |
GO:00086542 | Liver | HCC | phospholipid biosynthetic process | 150/7958 | 253/18723 | 4.77e-08 | 1.03e-06 | 150 |
GO:00066444 | Liver | HCC | phospholipid metabolic process | 214/7958 | 383/18723 | 7.25e-08 | 1.48e-06 | 214 |
GO:004648611 | Liver | HCC | glycerolipid metabolic process | 215/7958 | 392/18723 | 4.54e-07 | 7.49e-06 | 215 |
GO:00066504 | Liver | HCC | glycerophospholipid metabolic process | 168/7958 | 306/18723 | 7.27e-06 | 8.62e-05 | 168 |
GO:00066431 | Liver | HCC | membrane lipid metabolic process | 115/7958 | 203/18723 | 3.17e-05 | 3.22e-04 | 115 |
GO:004409111 | Liver | HCC | membrane biogenesis | 37/7958 | 55/18723 | 1.79e-04 | 1.41e-03 | 37 |
GO:0006665 | Liver | HCC | sphingolipid metabolic process | 85/7958 | 155/18723 | 1.27e-03 | 6.92e-03 | 85 |
GO:00066432 | Oral cavity | OSCC | membrane lipid metabolic process | 111/7305 | 203/18723 | 4.02e-06 | 4.69e-05 | 111 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SERINC1 | SNV | Missense_Mutation | rs536292960 | c.1303N>A | p.Val435Met | p.V435M | Q9NRX5 | protein_coding | tolerated(0.12) | possibly_damaging(0.498) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR |
SERINC1 | SNV | Missense_Mutation | novel | c.133N>G | p.Phe45Val | p.F45V | Q9NRX5 | protein_coding | tolerated(0.08) | benign(0.14) | TCGA-EO-A3AY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
SERINC1 | SNV | Missense_Mutation | novel | c.392C>G | p.Ala131Gly | p.A131G | Q9NRX5 | protein_coding | deleterious(0) | benign(0.022) | TCGA-EY-A1GV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | carboplatin | SD |
SERINC1 | SNV | Missense_Mutation | rs778207588 | c.275N>A | p.Arg92His | p.R92H | Q9NRX5 | protein_coding | deleterious(0.01) | probably_damaging(0.993) | TCGA-G3-AAUZ-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SERINC1 | SNV | Missense_Mutation | novel | c.623N>C | p.Leu208Pro | p.L208P | Q9NRX5 | protein_coding | deleterious(0) | probably_damaging(0.979) | TCGA-75-5122-01 | Lung | lung adenocarcinoma | Male | Unknown | I/II | Unknown | Unknown | PD |
SERINC1 | SNV | Missense_Mutation | novel | c.26N>T | p.Ser9Phe | p.S9F | Q9NRX5 | protein_coding | deleterious(0.01) | benign(0.067) | TCGA-78-7537-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SERINC1 | SNV | Missense_Mutation | novel | c.1114C>A | p.His372Asn | p.H372N | Q9NRX5 | protein_coding | tolerated(0.21) | benign(0) | TCGA-86-7701-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | etoposide | PD |
SERINC1 | SNV | Missense_Mutation | novel | c.80G>C | p.Arg27Pro | p.R27P | Q9NRX5 | protein_coding | tolerated(0.11) | possibly_damaging(0.703) | TCGA-58-8388-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SERINC1 | SNV | Missense_Mutation | novel | c.93N>A | p.Ser31Arg | p.S31R | Q9NRX5 | protein_coding | deleterious(0.04) | benign(0.213) | TCGA-77-6845-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SERINC1 | SNV | Missense_Mutation | rs745408354 | c.106N>G | p.Thr36Ala | p.T36A | Q9NRX5 | protein_coding | deleterious(0) | benign(0.34) | TCGA-90-A4EE-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | CR |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |